InvestorsHub Logo
Followers 0
Posts 2177
Boards Moderated 0
Alias Born 04/13/2018

Re: bwolfy2002 post# 195177

Monday, 11/29/2021 8:58:05 PM

Monday, November 29, 2021 8:58:05 PM

Post# of 233735
Fact:

At day 28 survival fell to 31%

Fact:

No clinical trial results support the assertion that Leronlimab works for COVID.

Fact:


CYDY stated that the company and it's officers were being investigated for statements regarding Leronlimab being an effective treatment for COVID.

Fact:


The FDA rebuked CYDY for pushing a false narrative. The SEC made CYDY remove "safe and effective," and Nader Pourhassan told Amarex to file an incomplete BLA to shore up CYDY's falling stock price.

The truth can't be hidden when the facts are in plain view.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News